Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Twist Bioscience Corporation is a diagnostics & research business based in the US. Twist Bioscience Corporation shares (TWST) are listed on the NASDAQ and all prices are listed in US Dollars. Twist Bioscience Corporation employs 525 staff and has a trailing 12-month revenue of around USD$101.1 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$18.52 - USD$214.07 |
---|---|
50-day moving average | USD$171.0964 |
200-day moving average | USD$113.7349 |
Wall St. target price | USD$153.75 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-4.792 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$101.1 million |
---|---|
Gross profit TTM | USD$28.7 million |
Return on assets TTM | -16.4% |
Return on equity TTM | -31.63% |
Profit margin | -115.92% |
Book value | $13.122 |
Market capitalisation | USD$6.6 billion |
TTM: trailing 12 months
There are currently 1.8 million Twist Bioscience Corporation shares held short by investors – that's known as Twist Bioscience Corporation's "short interest". This figure is 22.4% down from 2.4 million last month.
There are a few different ways that this level of interest in shorting Twist Bioscience Corporation shares can be evaluated.
Twist Bioscience Corporation's "short interest ratio" (SIR) is the quantity of Twist Bioscience Corporation shares currently shorted divided by the average quantity of Twist Bioscience Corporation shares traded daily (recently around 784200). Twist Bioscience Corporation's SIR currently stands at 2.35. In other words for every 100,000 Twist Bioscience Corporation shares traded daily on the market, roughly 2350 shares are currently held short.
However Twist Bioscience Corporation's short interest can also be evaluated against the total number of Twist Bioscience Corporation shares, or, against the total number of tradable Twist Bioscience Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Twist Bioscience Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Twist Bioscience Corporation shares in existence, roughly 40 shares are currently held short) or 0.0396% of the tradable shares (for every 100,000 tradable Twist Bioscience Corporation shares, roughly 40 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Twist Bioscience Corporation.
Find out more about how you can short Twist Bioscience Corporation stock.
We're not expecting Twist Bioscience Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Twist Bioscience Corporation's shares have ranged in value from as little as $18.52 up to $214.07. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Twist Bioscience Corporation's is 0.803. This would suggest that Twist Bioscience Corporation's shares are less volatile than average (for this exchange).
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.